Does ZOMETA Cause Hyperparathyroidism secondary? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hyperparathyroidism secondary have been filed in association with ZOMETA. This represents 0.9% of all adverse event reports for ZOMETA.
8
Reports of Hyperparathyroidism secondary with ZOMETA
0.9%
of all ZOMETA reports
4
Deaths
8
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From ZOMETA?
Of the 8 reports, 4 (50.0%) resulted in death, 8 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZOMETA. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ZOMETA Cause?
Osteonecrosis of jaw (386)
Pain (234)
Anxiety (195)
Dyspnoea (169)
Spinal osteoarthritis (166)
Osteoarthritis (160)
Arthralgia (156)
Exposed bone in jaw (153)
Osteomyelitis (152)
Death (147)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which ZOMETA Alternatives Have Lower Hyperparathyroidism secondary Risk?
ZOMETA vs ZONISAMIDE
ZOMETA vs ZOPICLONE
ZOMETA vs ZOTEPINE
ZOMETA vs ZUCLOPENTHIXOL
ZOMETA vs ZUCLOPENTHIXOL DECANOATE